(2.2) Dosage Forms and Strengths Injection: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg per 0.5 mL in single-dose pen or single-dose vial (3) Injection: 10 mg/2.4 mL (4.17 mg/mL) for four 2.5 mg/0.6 mL doses, 20 mg/2.4 mL (8.33 mg/mL) for four 5 mg/0.6 mL doses, 30 mg/2.4 mL (12.5 mg/mL) for four 7.5 mg/0.6 mL doses, 40 mg/2.4 mL (16.7 mg/mL) for four 10 mg/0.6 mL doses, 50 mg/2.4 mL (20.8 mg/mL) for four 12.5 mg/0.6 mL doses, or 60 mg/2.4 mL (25 mg/mL) for four 15 mg/0.6 mL doses in a multi-dose vial or single-patient-use KwikPen (3) Contraindications Warnings and Precautions Acute Pancreatitis: Has been observed in patients treated with GLP-1 receptor agonists, or MOUNJARO
Sleeve gastrectomy is a weight-loss surgery appropriate for people with higher BMIs over 40 or 35 with comorbid conditions
Epub 2024 Mar 29
CassinerioEOrofinoNRoghiADucaLPoggialiEFraquelliMet alCombination of deferasirox and deferoxamine in clinical practice: an alternative scheme of chelation in thalassemia major patients
Contact your healthcare team if you notice significant changes in your blood glucose levels
These effects may lead to lower fluid intake or increased fluid loss, resulting in mild dehydration. Even mild dehydration can affect bladder comfort and may increase the risk of urinary irritation, as reduced urine output means the urinary tract is flushed less frequently
